Approvals/CIMA-AEMPS/SORAFENIB SWANPOND INVESTMENTS 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Approved

STANDARD

SORAFENIB SWANPOND INVESTMENTS 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Swan Pond Investments Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: af85c6c0a6aecaf1
Drug Cima Aemps Name: SORAFENIB SWANPOND INVESTMENTS 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number: 85586
Holder Company Name: Swan Pond Investments Limited
Marketing Company Name: Swan Pond Investments Limited
Authorization Date: 2020-11-20
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 200 mg
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: No
Company Name: Swan Pond Investments Limited

SORAFENIB TOSILATO

274 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 20, 2020

Approval ID

af85c6c0a6aecaf1

Type

Standard